2nd Quarter - Report
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
Client
Income
—
Expenses
$180,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
House, Senate, FDA, Energy and Commerce and Labor-HHS Committee on Prescription Drug User Fee Act Agreement (PDUFA V), HR 4156, and S 2218; funding for National Center for Advancing Translational Sciences (NCATS) at NIH, FDA funding, NIH funding; FY13 Appropriations and Sequestration; CMS/Medicaid; Congressional CF Caucus; Patient Protection and Affordable Care Act and general health reform issues; Teen Advocacy Day and May Board on the Hill lobby days
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC CHAMBERLAIN | — |
| MARY B DWIGHT | Legislative Correspondent; Legislative Assistant |
| JACQUELINE ERDO | — |
| STEPHANIE KRENRICH | Sr. Leg. Asst.; Leg. Asst.; Leg. Aide; Leg. Corr. |
| JASON RANVILLE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.